[HTML] frontiersin.org

[HTML][HTML] Persisting reductions in cannabis, opioid, and stimulant misuse after naturalistic psychedelic use: An online survey

A Garcia-Romeu, AK Davis, E Erowid, F Erowid… - Frontiers in …, 2020 - frontiersin.org
Background Observational data and preliminary studies suggest serotonin 2A agonist
psychedelics may hold potential in treating a variety of substance use disorders (SUDs) …
被引用次数：110 相关文章

Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey

A Garcia-Romeu, AK Davis, E Erowid… - Frontiers in …, 2020 - jhu.pure.elsevier.com
Background: Observational data and preliminary studies suggest serotonin 2A agonist
psychedelics may hold potential in treating a variety of substance use disorders (SUDs) …

Persisting reductions in cannabis, opioid, and stimulant misuse after naturalistic psychedelic use: An online survey.

A Garcia-Romeu, AK Davis, E Erowid… - Frontiers in …, 2020 - psycnet.apa.org
Background: Observational data and preliminary studies suggest serotonin 2A agonist
psychedelics may hold potential in treating a variety of substance use disorders (SUDs) …
[PDF] academia.edu

[PDF][PDF] Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey. Front

A Garcia-Romeu, AK Davis, E Erowid, F Erowid… - Psychiatry, 2020 - academia.edu
Background: Observational data and preliminary studies suggest serotonin 2A agonist
psychedelics may hold potential in treating a variety of substance use disorders (SUDs) …
[HTML] nih.gov

[HTML][HTML] Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey

A Garcia-Romeu, AK Davis, E Erowid… - Frontiers in …, 2019 - ncbi.nlm.nih.gov
Background Observational data and preliminary studies suggest serotonin 2A agonist
psychedelics may hold potential in treating a variety of substance use disorders (SUDs) …
[HTML] frontiersin.org

[HTML][HTML] Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey

A Garcia-Romeu, AK Davis, E Erowid… - Frontiers in …, 2020 - frontiersin.org
Background Observational data and preliminary studies suggest serotonin 2A agonist
psychedelics may hold potential in treating a variety of substance use disorders (SUDs) …

Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey

A Garcia-Romeu, AK Davis, E Erowid… - Frontiers in …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Observational data and preliminary studies suggest serotonin 2A agonist
psychedelics may hold potential in treating a variety of substance use disorders (SUDs) …

Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey

A Garcia-Romeu, AK Davis, E Erowid… - Frontiers in …, 2020 - pure.johnshopkins.edu
Background: Observational data and preliminary studies suggest serotonin 2A agonist
psychedelics may hold potential in treating a variety of substance use disorders (SUDs) …

Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey.

A Garcia-Romeu, AK Davis, E Erowid… - Frontiers in …, 2020 - europepmc.org
Background Observational data and preliminary studies suggest serotonin 2A agonist
psychedelics may hold potential in treating a variety of substance use disorders (SUDs) …

Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey

A Garcia-Romeu, AK Davis, E Erowid… - Frontiers in …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Observational data and preliminary studies suggest serotonin 2A agonist
psychedelics may hold potential in treating a variety of substance use disorders (SUDs) …